Intersect ENT, Inc. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intersect ENT, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intersect ENT, Inc. for January 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Lucchese Cynthia L | Option Exercise | A | 33.95 | 2,797 | 94,958 | 2,797 | ||
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Kline Teresa L. | Option Exercise | A | 33.95 | 2,797 | 94,958 | 2,797 | ||
Jan 19 2018 | XENT | Intersect ENT, Inc ... | MOLL FREDERIC H | Option Exercise | A | 33.95 | 2,797 | 94,958 | 2,797 | ||
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Option Exercise | A | 33.95 | 119,000 | 4,040,050 | 119,000 | |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Sell | S | 33.47 | 11,166 | 373,695 | 484,683 | 495.8 K to 484.7 K (-2.25 %) |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Grant | A | 0.00 | 25,500 | 0 | 495,849 | 470.3 K to 495.8 K (+5.42 %) |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | A | 33.95 | 49,000 | 1,663,550 | 49,000 | |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Grant | A | 0.00 | 10,500 | 0 | 23,432 | 12.9 K to 23.4 K (+81.19 %) |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Option Exercise | A | 33.95 | 35,000 | 1,188,250 | 35,000 | |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Grant | A | 0.00 | 7,500 | 0 | 15,213 | 7.7 K to 15.2 K (+97.24 %) |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Kaufman Richard E | Sr VP& Chief Operat ... | Option Exercise | A | 33.95 | 28,000 | 950,600 | 28,000 | |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Kaufman Richard E | Sr VP& Chief Operat ... | Grant | A | 0.00 | 6,000 | 0 | 88,470 | 82.5 K to 88.5 K (+7.28 %) |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Option Exercise | A | 33.95 | 24,500 | 831,775 | 24,500 | |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Grant | A | 0.00 | 5,300 | 0 | 9,156 | 3.9 K to 9.2 K (+137.45 %) |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Parker Drake R. | Chief Business Offi ... | Option Exercise | A | 33.95 | 14,000 | 475,300 | 14,000 | |
Jan 19 2018 | XENT | Intersect ENT, Inc ... | Parker Drake R. | Chief Business Offi ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jan 18 2018 | XENT | Intersect ENT, Inc ... | Kaufman Richard E | Sr VP& Chief Operat ... | Sell | S | 32.98 | 25,000 | 824,490 | 82,470 | 107.5 K to 82.5 K (-23.26 %) |
Jan 18 2018 | XENT | Intersect ENT, Inc ... | Kaufman Richard E | Sr VP& Chief Operat ... | Sell | S | 33.69 | 25,000 | 842,163 | 107,470 | 132.5 K to 107.5 K (-18.87 %) |
Jan 16 2018 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Option Exercise | M | 12.19 | 10,000 | 121,900 | 40,000 | |
Jan 16 2018 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Sell | S | 34.35 | 10,000 | 343,476 | 3,856 | 13.9 K to 3.9 K (-72.17 %) |
Jan 16 2018 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Buy | M | 12.19 | 10,000 | 121,900 | 13,856 | 3.9 K to 13.9 K (+259.34 %) |
Jan 12 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,835 | 142,725 | 85,165 | |
Jan 12 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 33.81 | 12,835 | 433,890 | 12,932 | 25.8 K to 12.9 K (-49.81 %) |
Jan 12 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,835 | 142,725 | 25,767 | 12.9 K to 25.8 K (+99.25 %) |
Jan 03 2018 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | General Counsel | Payment of Exercise | F | 33.93 | 1,287 | 43,672 | 7,713 | 9 K to 7.7 K (-14.30 %) |
Jan 03 2018 | XENT | Intersect ENT, Inc ... | Kaufman Richard E | Sr VP& Chief Operat ... | Payment of Exercise | F | 33.93 | 1,287 | 43,672 | 132,470 | 133.8 K to 132.5 K (-0.96 %) |
Jan 03 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Payment of Exercise | F | 33.93 | 2,068 | 70,173 | 12,932 | 15 K to 12.9 K (-13.79 %) |
Jan 03 2018 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | President and CEO | Payment of Exercise | F | 33.93 | 6,834 | 231,897 | 470,349 | 477.2 K to 470.3 K (-1.43 %) |
Jan 03 2018 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Payment of Exercise | F | 33.93 | 644 | 21,853 | 3,856 | 4.5 K to 3.9 K (-14.31 %) |